160 related articles for article (PubMed ID: 19558502)
1. Effect of synthetic vernix biofilms on barrier recovery of damaged mouse skin.
Oudshoorn MH; Rissmann R; van der Coelen D; Hennink WE; Ponec M; Bouwstra JA
Exp Dermatol; 2009 Aug; 18(8):695-703. PubMed ID: 19558502
[TBL] [Abstract][Full Text] [Related]
2. Development of a murine model to evaluate the effect of vernix caseosa on skin barrier recovery.
Oudshoorn MH; Rissmann R; van der Coelen D; Hennink WE; Ponec M; Bouwstra JA
Exp Dermatol; 2009 Feb; 18(2):178-84. PubMed ID: 18684123
[TBL] [Abstract][Full Text] [Related]
3. Mimicking vernix caseosa--preparation and characterization of synthetic biofilms.
Rissmann R; Oudshoorn MH; Zwier R; Ponec M; Bouwstra JA; Hennink WE
Int J Pharm; 2009 May; 372(1-2):59-65. PubMed ID: 19429269
[TBL] [Abstract][Full Text] [Related]
4. Water-handling properties of vernix caseosa and a synthetic analogue.
Tansirikongkol A; Visscher MO; Wickett RR
J Cosmet Sci; 2007; 58(6):651-62. PubMed ID: 18305878
[TBL] [Abstract][Full Text] [Related]
5. Olopatadine hydrochloride accelerates the recovery of skin barrier function in mice.
Amano T; Takeda T; Yano H; Tamura T
Br J Dermatol; 2007 May; 156(5):906-12. PubMed ID: 17355233
[TBL] [Abstract][Full Text] [Related]
6. Long periodicity phase in extracted lipids of vernix caseosa obtained with equilibration at physiological temperature.
Rissmann R; Gooris G; Ponec M; Bouwstra J
Chem Phys Lipids; 2009 Mar; 158(1):32-8. PubMed ID: 18996362
[TBL] [Abstract][Full Text] [Related]
7. Epidermal barrier treatments based on vernix caseosa.
Visscher MO; Barai N; LaRuffa AA; Pickens WL; Narendran V; Hoath SB
Skin Pharmacol Physiol; 2011; 24(6):322-9. PubMed ID: 21822033
[TBL] [Abstract][Full Text] [Related]
8. Photostability and efficacy studies of topical formulations containing UV-filters combination and vitamins A, C and E.
Gaspar LR; Campos PM
Int J Pharm; 2007 Oct; 343(1-2):181-9. PubMed ID: 17614223
[TBL] [Abstract][Full Text] [Related]
9. Applying a vernix caseosa based formulation accelerates skin barrier repair by modulating lipid biosynthesis.
Boiten WA; Berkers T; Absalah S; van Smeden J; Lavrijsen APM; Bouwstra JA
J Lipid Res; 2018 Feb; 59(2):250-260. PubMed ID: 29217624
[TBL] [Abstract][Full Text] [Related]
10. New insights into ultrastructure, lipid composition and organization of vernix caseosa.
Rissmann R; Groenink HW; Weerheim AM; Hoath SB; Ponec M; Bouwstra JA
J Invest Dermatol; 2006 Aug; 126(8):1823-33. PubMed ID: 16628195
[TBL] [Abstract][Full Text] [Related]
11. Effect of vernix caseosa on the penetration of chymotryptic enzyme: potential role in epidermal barrier development.
Tansirikongkol A; Wickett RR; Visscher MO; Hoath SB
Pediatr Res; 2007 Jul; 62(1):49-53. PubMed ID: 17515835
[TBL] [Abstract][Full Text] [Related]
12. Barium sulphate with a negative zeta potential accelerates skin permeability barrier recovery and prevents epidermal hyperplasia induced by barrier disruption.
Fuziwara S; Ogawa K; Aso D; Yoshizawa D; Takata S; Denda M
Br J Dermatol; 2004 Sep; 151(3):557-64. PubMed ID: 15377340
[TBL] [Abstract][Full Text] [Related]
13. Lanolin-derived lipid mixtures mimic closely the lipid composition and organization of vernix caseosa lipids.
Rissmann R; Oudshoorn MH; Kocks E; Hennink WE; Ponec M; Bouwstra JA
Biochim Biophys Acta; 2008 Oct; 1778(10):2350-60. PubMed ID: 18655769
[TBL] [Abstract][Full Text] [Related]
14. Characterization of vernix caseosa as a natural biofilm: comparison to standard oil-based ointments.
Bautista MI; Wickett RR; Visscher MO; Pickens WL; Hoath SB
Pediatr Dermatol; 2000; 17(4):253-60. PubMed ID: 10990571
[TBL] [Abstract][Full Text] [Related]
15. Characterization of vernix caseosa: water content, morphology, and elemental analysis.
Pickens WL; Warner RR; Boissy YL; Boissy RE; Hoath SB
J Invest Dermatol; 2000 Nov; 115(5):875-81. PubMed ID: 11069626
[TBL] [Abstract][Full Text] [Related]
16. Neonatal skin maturation--vernix caseosa and free amino acids.
Visscher MO; Utturkar R; Pickens WL; LaRuffa AA; Robinson M; Wickett RR; Narendran V; Hoath SB
Pediatr Dermatol; 2011; 28(2):122-32. PubMed ID: 21504444
[TBL] [Abstract][Full Text] [Related]
17. Vernix caseosa in neonatal adaptation.
Visscher MO; Narendran V; Pickens WL; LaRuffa AA; Meinzen-Derr J; Allen K; Hoath SB
J Perinatol; 2005 Jul; 25(7):440-6. PubMed ID: 15830002
[TBL] [Abstract][Full Text] [Related]
18. Lipid mediator profile in vernix caseosa reflects skin barrier development.
Checa A; Holm T; Sjödin MO; Reinke SN; Alm J; Scheynius A; Wheelock CE
Sci Rep; 2015 Nov; 5():15740. PubMed ID: 26521946
[TBL] [Abstract][Full Text] [Related]
19. Ceramide analogue 14S24 selectively recovers perturbed human skin barrier.
Vávrová K; Hrabálek A; Mac-Mary S; Humbert P; Muret P
Br J Dermatol; 2007 Oct; 157(4):704-12. PubMed ID: 17711529
[TBL] [Abstract][Full Text] [Related]
20. Epidermal barrier lipids in human vernix caseosa: corresponding ceramide pattern in vernix and fetal skin.
Hoeger PH; Schreiner V; Klaassen IA; Enzmann CC; Friedrichs K; Bleck O
Br J Dermatol; 2002 Feb; 146(2):194-201. PubMed ID: 11903227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
